Quick Takeaways: Why It Matters? IFF is using PureStrong to push a dog-first probiotic paradigm—built on a single, canine-derived Limosilactobacillus reuteri strain, into a fast-growing, 3.2 billion dollar US pet supplement market that is stil...
Where Veterinary Science Meets Strategy
Quick Takeaways: Why It Matters? IFF is using PureStrong to push a dog-first probiotic paradigm—built on a single, canine-derived Limosilactobacillus reuteri strain, into a fast-growing, 3.2 billion dollar US pet supplement market that is stil...